Michael Salacz
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Immunotherapy and Immune Responses, Neuroblastoma Research and Treatments, Lung Cancer Treatments and Mutations
Most-Cited Works
- → First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma(2018)531 cited
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)373 cited
- → Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study(2015)231 cited
- → Anti-GPVI–associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface(2004)149 cited
- → Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma(2020)134 cited
- → When a Family Member Has a Malignant Brain Tumor(2008)78 cited
- → Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma(2014)76 cited
- → A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)(2019)70 cited
- → Ral signaling pathway in health and cancer(2017)60 cited
- → Profiles of brain metastases: Prioritization of therapeutic targets(2018)40 cited